IBSERNIS Trademark

Trademark Overview

On Wednesday, March 29, 2017, a trademark application was filed for IBSERNIS with the United States Patent and Trademark Office. The USPTO has given the IBSERNIS trademark a serial number of 87390649. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 28, 2020. This trademark is owned by Glaxo Group Limited. The IBSERNIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
ibsernis

General Information

Serial Number87390649
Word MarkIBSERNIS
Filing DateWednesday, March 29, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 28, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 26, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 4, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, December 28, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 28, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 25, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 24, 2020EXTENSION 5 GRANTED
Monday, February 17, 2020EXTENSION 5 FILED
Monday, February 24, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 17, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 17, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 17, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 17, 2020TEAS EXTENSION RECEIVED
Monday, December 2, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 2, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, November 16, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 14, 2019EXTENSION 4 GRANTED
Thursday, November 14, 2019EXTENSION 4 FILED
Thursday, November 14, 2019TEAS EXTENSION RECEIVED
Wednesday, November 13, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 13, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, May 11, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 9, 2019EXTENSION 3 GRANTED
Thursday, May 9, 2019EXTENSION 3 FILED
Thursday, May 9, 2019TEAS EXTENSION RECEIVED
Thursday, November 8, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 6, 2018EXTENSION 2 GRANTED
Tuesday, November 6, 2018EXTENSION 2 FILED
Tuesday, November 6, 2018TEAS EXTENSION RECEIVED
Friday, May 4, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 2, 2018EXTENSION 1 GRANTED
Wednesday, May 2, 2018EXTENSION 1 FILED
Wednesday, May 2, 2018TEAS EXTENSION RECEIVED
Tuesday, November 21, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 26, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 26, 2017PUBLISHED FOR OPPOSITION
Wednesday, September 6, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 15, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 14, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, August 13, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, August 13, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 8, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 8, 2017NON-FINAL ACTION E-MAILED
Thursday, June 8, 2017NON-FINAL ACTION WRITTEN
Monday, June 5, 2017ASSIGNED TO EXAMINER
Tuesday, April 4, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, April 1, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

ibsernis pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological